Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2005
10/27/2005US20050240167 Infusion device and driving mechanism for same
10/27/2005US20050240166 Implantable device, formulation and method for anti-psychotic therapy using risperidone
10/27/2005US20050240147 Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
10/27/2005US20050240138 Liner for patch
10/27/2005US20050239939 Block copolymer and nanofiller composites
10/27/2005US20050239905 Smooth muscle peristole inhibitor
10/27/2005US20050239900 Use of low molecular weight amino alcohols in ophthalmic compositions
10/27/2005US20050239895 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/27/2005US20050239894 Topical composition
10/27/2005US20050239884 Compositions comprising hmg-coa reductase inhibitor
10/27/2005US20050239871 Statins for the treatment of ocular hypertension and glaucoma
10/27/2005US20050239868 Indometacin preparation for external use
10/27/2005US20050239863 Indole diterpene natural product and synthetic compound; Potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye
10/27/2005US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/27/2005US20050239813 Pharmaceutical compositions comprising fk506 derivatives and their use for the treatment of allergic diseases
10/27/2005US20050239746 Pharmaceutical composition
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
10/27/2005US20050239724 Skin penetration enhancing components
10/27/2005US20050239715 Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester
10/27/2005US20050239714 Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide
10/27/2005US20050239698 placental growth factor (PLGF) capable of promoting neovascularization in the treatment of diseases and pathological alterations involving the cutaneous or subcutaneous connective tissue, scleroderma and skin ageing due to exposure to chemicals or solar radiation
10/27/2005US20050239692 Aqueous preparation containing oligopeptides and etherified cyclodextrin
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050239131 Interactive system for presenting and eliminating substances
10/27/2005US20050238736 Symplocos racemosa and/or Prosopis glandulosa extracts; bioassay
10/27/2005US20050238726 N-methyl D-aspartic acid (NMDA) receptor antagonism; neuroprotection
10/27/2005US20050238725 Nanoparticulate compositions having a peptide as a surface stabilizer
10/27/2005US20050238724 Pharmaceutical composition containing lamotrigine particles of defined morphology
10/27/2005US20050238723 Method of producing hydroxyalkyl starch derivatives
10/27/2005US20050238722 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
10/27/2005US20050238721 One step compounding extrusion of drug filled polymers
10/27/2005US20050238720 Stable pharmaceutical composition comprising erythropoietin
10/27/2005US20050238719 Film coating
10/27/2005US20050238718 Modified-release tablet of bupropion hydrochloride
10/27/2005US20050238717 Granules of a pharmaceutically active compound, amino acids and an intragranular polymer; and a hydrophilic extragranular polymer in which the granules are dispersed; extragranular polymer being more rapidly hydrating than intragranular polymer
10/27/2005US20050238716 Colloidal drug carrier system
10/27/2005US20050238715 Developing a delivery system for multi-pharmaceutical active materials at various release rates
10/27/2005US20050238714 Anti-fungal composition
10/27/2005US20050238712 Quickly disintegrating solid preparations
10/27/2005US20050238709 Methods and devices for providing prolonged drug therapy
10/27/2005US20050238708 Sealed capsule including an integrated puncturing mechanism
10/27/2005US20050238707 Method of cancer treatment
10/27/2005US20050238706 Pharmaceutically active lipid based formulation of SN-38
10/27/2005US20050238705 Lipid-based dispersions useful for drug delivery
10/27/2005US20050238704 Transdermal drug delivery method and system
10/27/2005US20050238703 Medical non-crosslinked pressure-sensitive adhesive composition, medical adhesive sheet employing the same, and process for producing medical non-crosslinked pressure-sensitive adhesive composition
10/27/2005US20050238701 Fibrous structures comprising a transferable agent
10/27/2005US20050238700 Paper tissue with high lotion transferability
10/27/2005US20050238699 Fibrous structures comprising a surface treating composition and lotion composition
10/27/2005US20050238698 Single-use cosmetic article
10/27/2005US20050238697 System and a method for starch-based, slow-release oral dosage forms
10/27/2005US20050238695 Lozenge for delivery of dextromethorphan
10/27/2005US20050238691 Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
10/27/2005US20050238676 Biliquid foam entrapment
10/27/2005US20050238675 Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
10/27/2005US20050238674 Stable injectable compositions
10/27/2005US20050238673 compound's solubility in a medium can be enhanced by forming de novo fatty acid or fatty alcohol derived micelles in the presence of the compound; contacting the compound with a fatty acid under conditions in which said fatty acid does not substantially form micelles such as low pH
10/27/2005US20050238672 Antifungal drug delivery
10/27/2005US20050238667 Botulinum toxin pharmaceutical compositions with enhanced potency with regard to a reference botulinum toxin pharmaceutical composition
10/27/2005US20050238664 Botulinum toxin pharmaceutical compositions with multiple stabilizers
10/27/2005US20050238663 Recombinant stabilizer botulinum toxin pharmaceutical compositions
10/27/2005US20050238638 Dietary Supplement that Serves as a Carbohydrate Blocker and Hangover Remedy
10/27/2005US20050238635 Use of hyrogen peroxide producting enzyme for treatment of otitis media
10/27/2005US20050238634 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
10/27/2005US20050238618 Low molecular weight polymers
10/27/2005US20050238616 Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
10/27/2005US20050238609 Cubic gel particles, uses thereof
10/27/2005US20050238606 Enhance delivery of oligonucleotides, nucleosides, nucleic acids by injection or applying on skin water solution of nucleic acid for delivery to hair follicles to inhibit hair growth
10/27/2005US20050238591 Tooth whitening substances
10/27/2005US20050238586 Preparation of further diagnostic agents
10/27/2005US20050238585 Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media
10/27/2005US20050238584 Sterically stabilized liposomes with hydrophilic polymers on surface; computed tomography
10/27/2005US20050236741 Process for the production of an abuse-proofed solid dosage form
10/27/2005DE202005013839U1 Tablet containing monobasic acid salt of clopidogrel, useful for preventing thromboembolic events, e.g. stroke or myocardial infarction, contains no ionic or basic auxiliaries or polyethylene glycol
10/27/2005DE102004016683A1 Dauerhaft geschäumte Zusammensetzung Permanently foamed composition
10/27/2005DE102004016591A1 Medizinische Pflaster mit verringertem Kleberrückstand Medical plaster with reduced adhesive residue
10/27/2005CA2847260A1 Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography
10/27/2005CA2564341A1 Transdermal delivery system for use with basic permeation enhancers
10/27/2005CA2563870A1 Pharmaceutical compositions comprising old man's beard (usnea barbata) and st.john's wort (hypericum perforatum) and their use
10/27/2005CA2563689A1 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005CA2563544A1 Lung surfactant supplements
10/27/2005CA2563371A1 Methods of manufacture and use of calcium phosphate particles containing allergens
10/27/2005CA2563104A1 Association between a heterocyclic compound and an antioxidant agent and pharmaceutical compositions containing them
10/27/2005CA2563069A1 Coating compositions for bioactive agents
10/27/2005CA2562932A1 Apparatus and method for transdermal delivery of influenza vaccine
10/27/2005CA2562806A1 Pharmaceutical compositions comprising an amphiphilic starch
10/27/2005CA2562699A1 Systems and methods for improving image-guided tissue ablation
10/27/2005CA2562606A1 Liquids containing suspended glass particles
10/27/2005CA2562495A1 Use of glycerol dipalmitostearate for improving the bioavailability of protein active ingredients in subcutaneous or intramuscular injectable formulations
10/27/2005CA2562391A1 Solid pharmaceutical preparation
10/27/2005CA2562242A1 Polycylic thiazoles as potassium ion channel modulators
10/27/2005CA2562081A1 Method for encapsulation of orally ingested materials to alter the site of digestion, site of action, or stability
10/27/2005CA2561124A1 Bazedoxifene acetate solid dispersion formulations
10/27/2005CA2560997A1 Delayed release formulations of 6-mercaptopurine
10/27/2005CA2560654A1 Imroved formulations of 6-mercaptopurine
10/27/2005CA2549341A1 Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography
10/27/2005CA2505469A1 Drug delivery device comprising a bilayered polymeric coating having a cell cycle inhibitor that acts selectively at the g1 phase of the cell cycle incorporated into the first polymer coating layer
10/26/2005EP1589067A1 Edible film
10/26/2005EP1589022A1 A mixture comprising fatty acid alcohols and APG-ether-carboxylate
10/26/2005EP1588732A1 Extractable filler for inserting medicine into animal tissue
1 ... 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 ... 2991